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Tuberculosis caused by Mycobacterium tuberculosis is currently one of the leading causes
of death from an infectious agent. The main difficulties encountered in eradicating this bac-
teria are mainly related to (i) a very complex lipid composition of the bacillus cell wall, (ii) its
ability to hide from the immune system inside the granulomas, and (iii) the increasing number
of resistant strains. In this context, we were interested in the Rv0646c (lipGMTB) gene located
upstream to the mmaA cluster which is described as being crucial for the production of cell
wall components and required for the bacilli adaptation and survival in mousemacrophages.
Using biochemical experiments combined with the construction of deletion and overexpres-
sion mutant strains in Mycobacterium smegmatis, we found that LipGMTB is a cytoplasmic
membrane-associated enzyme that displays both phospholipase and thioesterase activities.
Overproduction of LipGMTB decreases the glycopeptidolipids (GPL) level concomitantly to
an increase in phosphatidylinositol (PI) which is the precursor of the PI mannoside (PIM),
an essential lipid component of the bacterial cell wall. Conversely, deletion of the lipGMS
gene in M. smegmatis leads to an overproduction of GPL, and subsequently decreases the
strain susceptibility to various antibiotics. All these findings demonstrate that LipG is in-
volved in cell envelope biosynthesis/remodeling, and consequently this enzyme may thus
play an important role in mycobacterial physiology.
Introduction
With more than 10 million new cases and almost 1.6 million deaths in 2017, tuberculosis (TB) caused
by the etiologic agent Mycobacterium tuberculosis (M. tuberculosis) still remains the deadliest infec-
tious disease worldwide [1]. The current antibiotherapy, which is a combination of four antibiotics (i.e.
isoniazid (INH), rifampicin (RIF), pyrazinamide, and ethambutol), allows to heal 95% of infected people
with active disease when administered under directly observed therapy [2]. This treatment is, however,
not effective enough to overcome the emergence of multidrug and extensively drug-resistant strains of
M. tuberculosis [3,4]. More recently, some totally drug-resistantM. tuberculosis strains have also been
detected, which are virtually incurable [5]. Most of the time this antibiotic resistance is directly related
to the unique mycobacterial cell wall composition which is an essential factor contributing to virulence,
pathogenesis, and survival of the bacilli. Therefore, identifying proteins and mechanisms involved in the
biosynthesis and/or remodeling of this complex structure could lead to the development of new thera-
peutics to control and fight TB.
Indeed, amongst all bacterial phyla, Actinobacteria and more specificallyM. tuberculosis, possess an
unusual cell envelope with a specific architecture constituted by lipids which may represent up to 40–60%
of the dry weight of the cell, as compared with only 5–10% in other bacteria [6,7]. The outer membrane
is an extremely hydrophobic barrier mainly composed of long-chain mycolic acids (MAs) and several
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atypical lipids, which are responsible for the high intrinsic tolerance of the bacteria to various antibiotics [8]. More-
over, it is now acknowledged that most of these lipids play important roles in the viability and/or virulence of the
bacteria [9]. As a consequence, the structural characterization of these complex lipids, as well as their biosynthetic
pathways have been the subject of many studies in the past decade with the aim of identifying putative therapeutic
targets [10–12].
Of particular interest, the synthesis of MAs involves two fatty acid synthase (FAS) enzymatic complexes, FAS-I and
FAS-II [13,14]. FAS-I synthesizes de novo medium chain fatty acids (C16–18 and C24–26) as acyl-CoA derivatives,
which are further elongated by the FAS-II complex to form the C48–64 meromycolic chains, a major component of
the envelope arabinogalactan layer [13,14]. The various methyltransferases closely interact with enzymes belonging
to the FAS-II system to functionalize meromycolate chains by adding specific chemical modifications (such as cyclo-
propane, methyl, hydroxyl, and ketone) [14–18]. Amongst the eight putative methyltransferases identified inM. tu-
berculosis H37Rv genome, themmaA gene cluster; i.e.mmaA1 (Rv0645c),mmaA2 (Rv0644c),mmaA3 (Rv0643c),
andmmaA4 (Rv0642c); is essential for chemical group introduction and functionalization ofMas, thus participating
actively in the envelope integrity/virulence of M. tuberculosis [14,19,20].
Interestingly, these mmaA genes are also clustered with the Rv0646c gene, which is highly conserved amongst
mycobacterial species and encodes for LipG (LipGMTB), a putative lipase/esterase which has been recently described
as a carboxylesterase [21]. M. tuberculosis H37Rv genome encodes for 36 lipolytic enzymes annotated as putative
esterases, lipases, cutinases, or phospholipases based on their sequence homology and the presence of the consensus
G-x-S-x-G motif, characteristic of the α/β hydrolase-fold family [19,22–24]. LipGMTB has been classified within the
Lip family which includes 24 members [23,25]. This enzyme possesses approximately 50% sequence identity with the
EstB protein from Acinetobacter calcoaceticus and 43% with the putative hydrolase PA3586 from Pseudomonas
aeruginosaPAO1. Interestingly, theRv0646c gene has been annotated as essential forM. tuberculosisH37Rv survival
within primary murine cells by transposon site hybridization [26]. Due to its high conservation and its peculiar
location upstream to the mmaA cluster, which is crucial for the production of cell wall components and so for the
mycobacterial envelope integrity, the potential physiological function of LipG deserves to be studied and deciphered.
In this context, Rv0646c gene from M. tuberculosis H37Rv has been cloned, expressed, purified, and fully bio-
chemically characterized. Since its potential important role in mycobacterial lifecycle makes LipGMTB an attractive
target for future therapeutic developments against TB, inhibition studies on pure recombinant enzyme were also con-
ducted with two recent families of antitubercular compounds; namely, oxadiazolone-core (OX) derivatives [23,27],
and monocyclic analogs of Cyclophostin and Cyclipostins analogs (CyC) [28–30] which affect the growth of M. tu-
berculosis both in vitro and in infected macrophages.
In order to investigate the physiological function of LipG in mycobacterial species, both deletion and overexpres-
sion mutant strains have been generated into the surrogate strainMycobacterium smegmatis. By using phenotypic
assays, subcellular location, in silicomodeling, lipid extraction followed by TLC analysis, and susceptibility testing via
the resazurin microtiter assay (REMA), we determined that LipGMTB is a cytoplasmic membrane-associated enzyme
involved in phospholipids remodeling and cell wall integrity.
Experimental procedures
Bacterial strains and culture conditions
Escherichia coli DH10β and E. coli C41 (DE3)/pLyS strain were cultured in LB broth or Terrific Broth (Invitrogen,
France).M. smegmatis mc2 155 andM. smegmatis mc2 155 groEL1ΔC [31] strains were cultured in Middlebrook
7H9 broth (BD Difco, Le Pont-de-Claix, France) supplemented with 0.05% (v/v) Tween-80 and 0.2% (v/v) glycerol
(Sigma–Aldrich, Saint-Quentin Fallavier, France) (7H9-S). When needed, ampicillin and kanamycin (Euromedex,
Souffelweyersheim, France) were added to the medium at final concentrations of 100 and 50 μg/ml for both E. coli
and mycobacterial species, respectively. Hygromycin B (Euromedex) was used at a final concentration of 200 and 50
μg/ml for recombinant E. coli and recombinant mycobacteria, respectively.
In silico analyses
Genomic sequences of lipG and its orthologs were obtained from the NCBI database.M. tuberculosis H37Rv,My-
cobacterium leprae TN,M. marinum M, andM. smegmatis genomic clusters were re-adjusted manually based on
the genomic annotations provided by the Mycobrowser database [32]. The amino acid sequence of M. tuberculosis
H37Rv LipG and its orthologs were aligned using Multalign software [33] and results were displayed using ESPrit 3.0
software [34]. The percentage of identity between the different orthologs was generated with the Clustal multiple se-
quence alignment program (http://www.ebi.ac.uk/Tools/msa/clustalo/). A 3Dmodel of M. tuberculosis H37Rv LipG
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(LipGMTB) was also generated, by using the I-TASSER server [35,36] and visualized with PyMOL software (The Py-
MOL Molecular Graphics System, version 1.8 Schro¨dinger, LLC). Electrostatic surface potentials of LipGMTB model
structure was built using freely available PDB2PQR web service [37,38]. The electrostatic potential data thus gener-
ated, were further visualized using the PyMOL APBS Tools 2 plugin [39].
Construction of recombinant plasmids, expression and puriﬁcation of
recombinant LipGMTB protein
Rv0646c ORF encoding LipGMTB protein, was amplified from M. tuberculosis H37Rv genomic DNA by polymer-
ization chain reaction, using primers containing the attB1, Shine–Dalgarno, 6× His, and a TEV (tobacco etch virus)
NIa site sequences at the 5′-end and the attB2 recombination site at the 3′-end (Supplementary Table S1, P1MTB
and P2MTB). The resulting PCR fragments were cloned using the Gateway R© technology (Invitrogen, Carlsbad, CA,
U.S.A.) into the pDonR221 entry vector, and then into the pDEST14 expression vector (pDEST14::lipGMTB). A simi-
lar strategy was used to clone theMSMEG 1352 ORF encoding LipGMS protein. PCR was performed with P1MS and
P2MS primers (Supplementary Table S1), thus giving the pDEST14::lipGMS construct. DNA sequences of recombinant
clones were analyzed by GATC Biotech (Ebersberg, Germany). The newly generated pDEST14::lipGMTB was used as
a template for generating pDEST14::lipGMTBS123Aby PCR mutagenesis using specific primers (Supplementary Ta-
ble S1, P3 and P4). The resulting plasmids pDEST14::lipGMTB , pDEST14::lipGMTBS123A , and pDEST14::lipGMS were
used to transform E. coli C41 (DE3)/pLyS strain harboring the pRare plasmid (Novagen).
For protein expression, 1 L of Terrific Broth medium was inoculated with the recombinant strains at initial OD600
of 0.05, andwas further incubated at 37◦C and 200 rpm.When theOD600 reached 0.6, cells were put on ice for 30min.
Then, 0.5 mM isopropyl-d-thiogalactopyranoside was added to the medium and the culture was further incubated
at 17◦C under shaking. After 18 h of incubation, cells were pelleted, re-suspended in 30 ml of ice-cold lysis buffer (50
mM Tris/HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.1% (v/v) Triton X-100, 0.25 mg/ml lysozyme), and stored at
−80◦C. To purify recombinant LipGMTB or LipGMS, the supernatant (S1) obtained after cell lysis and centrifugation
at 17000×g for 30 min, was stored at 4◦C. Pellet was then re-suspended in lysis buffer, sonicated twice for 30 s with
30 s breaks between each cycle, solubilized by stirring at 4◦C for 1 h using a magnetic bar, and further centrifuged at
17000×g for 30min (giving S2 supernatant). Both supernatants (S1 and S2) were pooled and loaded on to aNi2+-NTA
affinity column previously equilibrated with buffer A (10 mM Tris/HCl pH 8.0, 150 mM NaCl). The column was
washed with buffer A before performing elution with buffer A and 125 and 250 mM of imidazole. Fraction purity
was assessed on SDS/PAGE. The corresponding 35 kDa protein band was further analyzed by tryptic digestion and
MS. Pure protein was concentrated to 0.5–1 mg/ml, flash frozen in liquid nitrogen, and stored at −80◦C.
Biochemical characterization and inhibition of rLipGMTB/MS
Esterase activity assay
The esterase activity of rLipGMTB or rLipGMS was determined as described previously [23] with slight modifica-
tions. Briefly, p-nitrophenyl (pNP) esters with different carbon chain lengths were used as substrates, including
pNP acetate (pNP-C2), butyrate (pNP-C4), caproate (pNP-C6), caprylate (pNP-C8), caprate (pNP-C10), laurate
(pNP-C12), myristate (pNP-C14), and palmitate (pNP-C16). Stock solution (200 mM) of each substrate was freshly
prepared in acetonitrile. Release of pNP was monitored at 410 nm and pH 8 using a 96-well plate spectrophotome-
ter (PowerWaveTM, Bio-Tek Instruments) and quantitated using a pNP calibration curve (10 μM to 0.5 mM) with
(λ = 410 nm) = 6.0 mM−1. Enzymatic reactions were performed at 37◦C over a period of 20 min in a 96-well microplate
filled with 10 mM Tris buffer (pH 8.0) containing 150 mM NaCl with 0.5% (v/v) Triton X-100 to a final volume of
200 μl. In each well, 2 mM of substrate and 1 μg of rLipGMTB (0.15 μM final concentration) were added. Activities
were expressed in international units (U), corresponding to 1 μmol of pNP released per min. Specific activities (S.A)
were expressed as U/mg of pure enzyme. Experiments were done in triplicate.
Phospholipase A1 and A2 activities assay
The phospholipase A1 and A2 activities of rLipGMTB and rLipGMS were monitored continuously using BODIPYH
dye-labeled phospholipids: PED-A1 (N-((6-(2,4-DNP)Amino)Hexanoyl)-1-(BODIPYH FL C5)-2-hexyl-sn-glycero-
3-phosphoethanolamine) and red/green BODIPYH PC-A2(1-O-(6-BODIPYH558/568-aminohexyl)-2-BODIPYH
FLC5-sn-glycero-3-phosphocholine), respectively, as previously described [40,41]. Briefly, substrate stock solutions
(50 μM) were prepared in ethanol. All enzyme activities were assayed in 10 mM Tris (pH 8.0), 150 mM NaCl. En-
zymatic reactions were performed at 25◦C for 60 min in a final volume of 200 μl containing 1.5 μg rLipGMTB (0.23
μM final concentration) and 5 μM substrate. The release of BODIPYH (BFCL5) (Life Technologies) was recorded
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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at λexc = 485 nm and λem = 538 nm using a 96-well plate fluorimeter (Fluoroskan Ascent, Thermo Fisher Scien-
tific). Each experiment was done in triplicate. Enzymatic activities were quantitated using a BFCL5 calibration curve
(0.08–200 pmoles). S.A were expressed in mU of fatty acid (or BFLC5) released per mg of pure protein (mU.mg−1).
One unit correspond to the release of one μmol of product release per min. PLA1 from T. lanuginosus and Bv PLA2
(Sigma–Aldrich) were used as positive standards for the PLA1 and the PLA2 activities, respectively.
Thioesterase activity assay
Hydrolysis of palmitoyl-Coenzyme A (palmitoyl-CoA) (Sigma–Aldrich) was used to measure thioesterase
activity. After the hydrolysis of the thioester bond, the free sulphur on CoA is attacked by DTNB
(5-5′-Dithio-bis 2-nitrobenzoic acid) (Sigma–Aldrich) which releases a measurable nitrophenyl group, TNB2−
(5-Thio-2-nitrobenzoate) ion detectable at 415 nm. Fresh stock solution of palmitoyl-CoA (1 mM) and DTNB (0.4
mM) were prepared in water. Palmitoyl-CoA and DTNBwere added in each well of a 96-well plate at final concentra-
tion of 10 μM. The thioesterase activity of rLipGMTB or rLipGMS (30 μg) was compared with that of TesA (Rv2928)
[42] and LipY [43] used as positive and negative controls, respectively. Triplicate assays were done at 37◦C in 10 mM
Tris (pH 8.0) 150 mMNaCl buffer. The absorbance at 415 nm was continuously measured and the release of TNB2−
was quantitated using a calibration curve (0.5–30 nmoles).
Enzymatic inhibition assays using OX derivatives, CyC analogs, and
Orlistat
The six oxadiazolone derivatives (OX); i.e.MmPPOX, iBPOX, iBpPPOX, HPOX, HpPPOX, and BePOX; were syn-
thesized as described previously [23,27]. The five CyC analogs; i.e. CyC17, CyC7α, CyC7β, CyC8α, and CyC8β; were
synthesized according to [44–46].
Inhibition experiments were performed using the classical enzyme-inhibitor pre-incubation method, as described
previously [30,47,48]. Stock solutions (10 mM) of each CyC and OX inhibitor, as well as Orlistat were prepared in
DMSO. rLipGMTB was pre-incubated for 30 min at 25◦C with each compound at various inhibitor molar excess (xI),
related to 1 mol of enzyme, ranging from 1 to 200. Sample of the incubation medium (1.0 μg rLipGMTB) was then
collected for measuring the enzyme residual activity using the colorimetric assay with the substrate pNP-C6, as de-
scribed above. The variation in the residual activity allowed to determine the inhibitor molar excess which reduced
the enzyme activity to 50% of its initial value (xI50) [47,48]. Thereby, a xI50 value of 0.5 is corresponding to a 1:1 sto-
ichiometric ratio between the enzyme and the inhibitor, and is therefore the highest level of inhibitory activity that
can be achieved. In each case, control experiments were done in the absence of inhibitor but with the same volume of
solvent. It is worth noting that DMSO at a final volume concentration of less than 10% has no effect on the enzyme
activity. Inhibition dose–response curves were fitted in Kaleidagraph 4.2 Software (Synergy Software). Results are
expressed as mean values +− S.D. of at least three independent assays.
Creation of M. smegmatis MSMEG 1352 disrupted strain
The MSMEG 1352 gene encoding LipGMS was amplified with 500-bp flanking regions by PCR using M. smegma-
tis mc2 155 genomic DNA as template and specific primers (Supplementary Table S1, P9 and P10). PCR product
of ∼2000 bp was cloned into pJET1.2/blunt vector following manufacturer’s instructions giving pJET-lipGMS . Re-
combinant plasmid was then digested with NruI, and a hygromycin resistance cassette amplified from pUC-Hygro
using primer (Supplementary Table S1, P17 and P18). The resulting blunt-ended PCR product was cloned in order
to disrupt lipGMS gene. This new plasmid, pJET-lipGMS::Hyg which contains an inactive version of lipGMS gene was
used as template for amplifying an allelic exchange substrate by using specific primers (Supplementary Table S1, P9
and P10). Approximately 300 ng of purified PCR product was electroporated into electro-competentM. smegmatis
mc2 155 strain harboring pJV53 plasmid, and cells were plated on to Middlebrook 7H10 agar medium supplemented
with 50 μg/ml of both kanamycin and hygromycin and incubated at 37◦C during 5 days as previously described [49].
Finally, recombinant clones were analyzed by PCR using P7-P8 and P11-P12 primers’ pairs (Supplementary Table
S1).
Creation of overexpression/complementation vectors
ORFs Rv0646c and MSMEG 1352 were amplified by PCR with specific primers (Supplementary Table S1, P5–P6
and P7–P8) containing NdeI and BamHI restriction sites in 5′ and 3′ ends, respectively. Digested and purified prod-
ucts were cloned into the pVV16 mycobacterial expression vector in frame with the 6His-tag located in C-terminal
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position giving the pVV16::lipGMTB and pVV16::lipGMS complementation plasmids allowing a constitutive produc-
tion of recombinant LipG. Rv0646c ORFs was also cloned within a homemade pMyC Gateway R© vector, allowing a
strong overexpression following acetamide induction, thus giving pMyC::lipGMTB . Competent M. smegmatis mc2
155, M. smegmatis groEL1ΔC, and lipGMS ::Hyg cells were prepared as previously described [50] and were elec-
troporated with a single pulse of 2.5 kV, 25 μF, and 1000 by using a Gene Pulser XcellTM Electroporation System
(Bio-Rad). Selection was achieved by plating cells on complete Middlebrook agar medium supplemented with the
proper antibiotic.
Subcellular fractionation and immunoblotting
Recombinant M. smegmatis groEL1ΔC harboring pVV16::lipGMTB and pVV16::lipGMS were cultured in 7H9-S
medium supplemented with 50 μg/ml kanamycin until OD600 was approximately 1–1.5. Cells were harvested for 10
min at 4000×g, then washed twice with PBS (pH 7.4) buffer containing 0.05% (v/v) Tween-20, and re-suspended in
lysis buffer (PBS pH 7.4 containing EDTA and 1mMPMSF). Cells were then disrupted by using a French pressure cell
at 1100 psi. Subcellular fractionation was performed as previously described [51] with slight modifications. Briefly,
the cell lysate was centrifuged two times at 1000×g at 4◦C in order to remove unbroken cells. Supernatant (total lysate)
was further centrifuged two times at 27000×g at 4◦C to separate cell wall/membrane from the cytoplasmic fraction.
The pellet containing insolublematerial was washed twice with PBS (pH 7.4) to remove any cytoplasmic contaminant,
and supernatant containing the cytoplasmic fraction was further ultracentrifuged at 100000×g for 90 min at 4◦C to
remove anymembrane contaminant. Each fractionwas loaded and separated on to 12%SDS/PAGEand transferred on
to a nitrocellulosemembrane using a Trans-Blot Turbo Transfer System (Bio-Rad). Immunoblotting of 6×His-tagged
proteinswas performedusing anti-HisProbeTM HRP conjugate (ThermoFisher Scientific).MSMEG 0220was used as
the control for subcellular location, and immunoblotting was performed by using rabbit polyclonal antibodies [52,53]
and horseradish peroxidase–conjugated anti-rabbit IgG (Sigma-Aldrich). Revelation was achieved using PierceTM
ECLWestern Blotting substrate solution (Thermo Fisher Scientific) and visualized with a ChemiDocTM MP Imaging
System (Bio-Rad).
Genapol R© extraction and immunoblotting
Approximately 10 uOD600 of recombinant cells cultured in 7H9-S medium supplemented with 50 μg/ml kanamycin
at OD600 ∼1-1.5 were harvested for 10 min at 4000×g. Cells were washed twice in PBS (pH 7.4) buffer contain-
ing 0.05% (v/v) Tween-20 and surface-exposed proteins were isolated by incubating cells with PBS containing 0.5%
(v/v) Genapol R©-X080 (Sigma–Aldrich) at room temperature [54,55]. Control samples were treated with a PBS buffer
without Genapol R©-X080. After approximately 30 min, all supernatants were collected and precipitated with 12%
(v/v) trichloroacetic acid. Finally, samples were separated on to 12% SDS/PAGE and immunoblotting was achieved
as described above.
Dynamic subcellular location using ﬂuorescence microscopy
Gene encoding superfolder GFP (sfGFP) was amplified from pKD4-sfGFP plasmid with specific primers (Supple-
mentary Table S1, P13–P15 and P14–P15) which were cloned in pMV261 and pVV16 vectors at either EcoRI/HindIII
or only HindIII restriction sites. Thus, creating pMV261::sfGFP and pVV16::sfGFP. Rv0646c and MSMEG 1352
ORFs were amplified by PCR with specific primers (Supplementary Table S1, P5–P6 and P7–P8) containing NdeI
and BamHI restriction sites in 5′ and 3′ ends, respectively. Digested and purified products were cloned into the
pVV16::sfGFP in frame with the sfGFP gene and thus generating a translational fusion.M. smegmatis was electro-
porated with 1.5 μg of pMV261::sfGFP and these latter constructs; recombinant clones were selected on to specific
medium and overexpression of the two chimeric proteins were checked by immunoblotting as described above. Re-
combinant strains were cultured until OD600 reaches ∼1-1.5, and then harvested by centrifugation at 4000×g for 10
min. Cells were washed once in PBS (pH 7.4) buffer, and bacterial suspension (5 μl) was spotted between a coverslip
of 170 μm thickness and a 1.5% agarose-PBS pad. Bacteria were analyzed by snapshot imaging at room tempera-
ture using an Olympus FV1000 confocal microscope and 100× oil-objective. Exposure time was 800 ms for both
phase-contrast and fluorescence images (λexc \ λem = 490/530 +−10 nm). Images recorded were processed using the
open source program ImageJ 1.51K (NIH, U.S.A.).
Lipid extraction and analysis
Mycobacterial strains were grown in 1 l of 7H9-S broth until an OD600 of ∼1 was reached, except when using ac-
etamide inducible strains where cells were collected at specific time points. Cultures were then centrifuged at 4000g
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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for 15 min at 4◦C and washed twice with distilled water. Pellets were lyophilized overnight and weighed to determine
the exact mass of bacterial dry extract for normalization calculations.
MAs methyl esters (MAMEs) and fatty acids methyl esters (FAMEs) were extracted following previously de-
scribed protocol [56,57]. Approximately, 10 mg of cellular dry weight were re-suspended in 2 ml TBAH (40% v/v,
Sigma–Aldrich) and incubated at 100◦C overnight. Then 4 ml of CH2Cl2, 300 μl CH3I, and 2 ml of water were added
to the mixture and incubated for 1 h at room temperature under shaking. Sample was centrifuged and the lower
organic phase was kept, washed three times with distilled water, dried over MgSO4, and then concentrated under
nitrogen stream. Finally, 3 ml of DTT were added to the dried extract, and sonication was performed for 10 min in a
water bath. Sample was centrifuged for 10 min at 4000×g to remove any precipitate. The DTT layer was evaporated
and the residue was re-suspended in 100μl of DTT. The same volume of extract containingMAMEs and FAMEswere
separated on 1D TLC using hexane/ethyl acetate (19:1, v/v) as eluent, and revealed by using a 10% phosphomolybdic
acid solution in absolute ethanol.
Total lipids were extracted as previously described [58] with slight modifications. Briefly, lipids from dry extract
were incubated for 16 h with CHCl3-MeOH (1:2; v/v), at room temperature under shaking. Residual lipids were
re-extracted for 16 h with the same solvents, but using alternative ratios (1:1 and 2:1 v/v). All the three organic
phases were pooled and concentrated under reduced pressure. Samples were re-suspended in a CHCl3-MeOH so-
lution (3:1, v/v), and washed with 0.3% (w/v) NaCl in water. Organic and aqueous phases were separated by centrifu-
gation 4000×g for 10 min, and only the organic phases were conserved and dried over MgSO4. Samples were finally
evaporated under a nitrogen stream, weighed, and re-suspended in a CHCl3-MeOH solution (3:1, v/v).
Equal volume of extract containing glycopeptidolipids (GPLs) were separated on TLC (Silica Gel 60, Merck) by
using CHCl3-MeOH (90:10, v/v) as eluent and further visualized by vaporization of 20% (v/v) sulphuric acid in
ethanol. Phospholipid analyses were carried out by using both 1- or 2D TLC. Mono-dimensional TLC were per-
formed by loading the same volume of extract and using CHCl3-MeOH-H2O (65:25:4; v/v/v) as eluent. Concerning
bi-dimensional TLC, the first dimension was resolved by using CHCl3-MeOH-H2O (65:25:4; v/v/v) as solvent system
1, and CHCl3-MeOH-CH3COOH-H2O (80:12:15:3; v/v/v/v) as solvent system 2. Phospholipids were visualized by
vaporization of a copper acetate/orthophosphoric acid mixture prepared by mixing a copper acetate saturated so-
lution with a 85% (1:1, v/v) aqueous orthophosphoric acid solution. Phospholipid standards were purchased from
Sigma–Aldrich. Finally, each resolved plate was heated at 120◦C for 5–10 min, scanned using a ChemiDocTM MP
Imaging System (Bio-Rad), and densitometric analyses was performed using the ImageLabTM software version 5.0
(Bio-Rad) allowing to determine the relative content of each sample.
REMA for MIC determination
Susceptibility testing was performed using the Middlebrook 7H9 broth microdilution method. All assays for each
strain were carried out at least in triplicate. MICs against the variousM. smegmatis bacterial strains were determined
in 96-well flat-bottom Nunclon Delta Surface microplates with lid (Thermo Fisher Scientific) using REMA method
[59]. Briefly, log-phase bacteria were diluted to a cell density of 5× 106 cells/ml in 7H9-Smedium. Then 100 μl of the
above inoculum (i.e. 5× 105 cells per well) was added to eachwell containing 100μl of 7H9-Smedium, serial two-fold
dilutions of the selected antibiotics (RIF or INH), CyC17 [28,29],HPOX [27], orOrlistat to a final volume of 200 μl.
Growth controls containing no inhibitor (i.e., bacteria only), inhibition controls containing 50 μg/ml kanamycin
and sterility controls (i.e. medium only) without inoculation were also included. Plates were incubated at 37◦C in
a humidity chamber [60] to prevent evaporation for 3–5 days. Then, 20 μl of a 0.02% (w/v) resazurin solution was
added to each well, and the plates were incubated at 37◦C for color change from blue to pink or violet and for a
reading of fluorescence units (FU). Fluorescence corresponding to the resazurin reduction to its metabolite resorufin
was quantitated using a Tecan Spark 10Mmultimode microplate reader (Tecan Group Ltd, France) with excitation at
530 nm and emission at 590 nm. Fluorometric MICs were determined by fitting the RFU% sigmoidal dose–response
curves [28,29] in Kaleidagraph 4.2 software (Synergy Software). MIC values determined as the lowest compound
concentrations inhibiting 50% of growth were defined as the MIC50.
Results
LipG is a highly conserved mycobacterial protein
GeneRv0646c encoding LipGMTB protein was not only foundwithinM. tuberculosis genome. Genomic context con-
taining Rv0646c gene and its orthologs was indeed surprisingly highly conserved withinmanymycobacterial species.
In M. tuberculosis, Rv0646c is surrounded by an essential uncharacterized gene (Rv0647c) and the mmaA cluster
composed of four mmaA genes (mmaA1–4) encoding proteins involved in MAs maturation processes (Figure 1).
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Figure 1. Genomic organization of lipG clusters in mycobacterial species
Schematic organization of the lipG genomic loci from M. tuberculosis, M. leprae, M. marinum, and M. smegmatis were designed
based on the Mycobrowser database [32]. lipG genes are represented in yellow whereas genes involved in MAs maturation pro-
cesses are in black. Furthermore, a conserved ORF encoding a putative ABC transporter was highlighted in red. Co-ordinates of
each gene cluster are indicated in kb. Scale represents 500 bp.
Interestingly, the occurrence and genome organization of lipG clusters are also highly conserved inM. tuberculosis,
M. leprae,M. marinum, orM. smegmatis genomes (Figure 1), with two copies of genes encoding for LipG proteins
inM. marinum,M. abscessus, orM. ulcerans genomes. Multiple sequence alignment of these various LipG proteins
and sequence comparison, revealed a high level of amino-acid conservation, also with some consensus amino-acids
blocks between each mycobacterial species [21] (Supplementary Figure S1). The LipG characteristics (i.e. sizes of
genes/proteins and sequence identities) from different mycobacterial strains are summarized in Table 1. Each of these
proteins possess a molecular weight ∼32 kDa, with the number of amino acids ranging from 301 to 324. Taken to-
gether, all these findings suggest that the cluster including the lipG genemay be dedicated to a commonmycobacterial
feature either in strict pathogenic, opportunistic, or non-pathogenic strains.
Cloning, expression puriﬁcation, and biochemical characterization of
LipGMTB
In an attempt to characterize LipG biochemical activities more finely, to confirm its carboxylesterase properties [21],
and also to decipher the physiological role of this protein, the Rv0646c andMSEG 1352 genes have been cloned. The
respective recombinant rLipGMTB and rLipGMS were produced in E. coli C41 (DE3)/pLyS strain harboring the pRare
plasmid. rLipGMTB and purification was achieved using Ni2+-NTA affinity chromatography, yielding ∼1 mg of pure
recombinant protein per culture liter. The purity and the expected molecular weight (∼35 kDa) were confirmed by
12% SDS/PAGE (Figure 2A) and MALDI-TOF analysis.
The esterase activity of rLipGMTB was first assayed using pNP esters with various carbon chain lengths ranging
from C2 to C16 (Figure 2B). Whatever their chain length, rLipGMTB was able to hydrolyze all pNP esters, therefore
displaying a large substrate specificity as previously reported by Rastogi et al. [21]. While similar S.A were obtained
with short pNP-C4 and medium pNP-C8 esters (mean S.A = 4.26 +− 0.11 U/mg). However, rLipGMTB exhibited a
clear significant preference for pNP-C6 ester with a S.A value of 6.12 +− 0.17 U/mg. For pNP esters carrying more
than eight carbon atoms, this S.A dropped sharply to 2.6 +− 0.18, 2.1 +− 0.21, 0.53 +− 0.08, and 0.19 +− 0.01 U/mg for
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Table 1 Conservation and characteristics of mycobacterial LipG proteins
Mycobacterial
species/strains LipG and orthologs
Gene Gene ID Protein Protein size (aa) Identity1 (%)
M. tuberculosis H37Rv Rv0646c 888065 LipG 301 -
M. bovis AF2122/97 Mb 0665c 1091775 LipG 301 100
M. bovis BCG Pasteur
1173P2
BCG 0695c 4697156 LipG 301 100
M. canetti CIPT
140010059
MCAN 06451 10986452 LipG 301 99
M. leprae TN ML 1899 910591 LipG 305 71
M. marinum M MMAR 0981 6225233 LipG1 315 73
MMAR 0983 6225235 LipG2 310 47
M. ulcerans Agy99 MUL 0733 4552132 LipG1 314 73
MUL 0735 4552134 LipG2 303 47
M. abscessus ATCC
19977
MABS 3878 5967421 LipG2 310 40
MABS 3880 5966346 LipG1 324 54
M. smegmatis mc2155 MSMEG 1352 4534086 LipG 305 64
1Amino-acid sequence identity related to M. tuberculosis H37Rv.
Figure 2. Puriﬁcation and biochemical characterization of recombinant rLipGMTB
(A) Purity assessment of rLipGMTB. rLipGMTB (5 μg) was loaded on to 12% polyacrylamide gel. Unstained protein molecular weight
marker was used as standard (Euromedex). (B) Carboxylesterase S.A determination on pNP-ester substrates with chain lengths
varying from C2 to C16. (C) Thioesterase activity measurements corresponding to palmitoyl-CoA hydrolysis. (D) PLA1 and PLA2
activity using fluorescent phospholipids. TL PLA1, Bv PLA2, and LipY were used as positive and negative controls, respectively. (E)
PLA1 enzymatic activity of the rLipGMTBS123A compared with rLipGMTB. Results are expressed as relative activity in %. Each result
is expressed as mean values +− S.D. of at least three independent assays. Abbreviation: Bv PLA2, Bee venom PLA2, TL PLA1, T.
lanuginosus lipase PLA1.
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pNP-C10, pNP-C12, pNP-C14, and pNP-C16, respectively (Figure 2B). Interestingly, amongst the Lip protein family
member’s, rLipGMTB substrate specificity using pNP esters was similar to those of the esterase’s LipU and LipR [23].
The lipase activity of rLipGMTB has also been tested using a large panel of triacylglycerol (TAG) substrates, such
as trioctanoin and triolein using the pH-stat technique, and pomegranate oil-coated TAG method [48]. In all cases,
rLipGMTB was not able to hydrolyze any of these TAGs, even when using highly sensitive fluorogenic TAG substrates
[40]. It is well known that lipases differ from esterases by their ability to hydrolyze long-chain acylglycerols at the
oil–water interface, whereas esterases can only hydrolyze substrates with short- or medium-fatty acid chains [61].
From these findings, rLipGMTB could be considered as a true carboxylesterase, as recently proposed by Rastogi et al.
[21].
Due to its genomic localization in the same cluster as themmaA genes encoding for methyltransferase proteins, it
is tempting to suggest that rLipGMTB might also be able to hydrolyze the thioester bond of acyl-CoA or MA interme-
diates as previously shown for Cut6 (Rv3802c). Cut6 is an essential bifunctional phospholipase A and thioesterase en-
zyme belonging to the Cutinase-like family proteins fromM. tuberculosis [62]. Thioesterases are a group of enzymes
that catalyze the hydrolysis of a thioester bond between a carbonyl group and a sulphur atom. Here, the hydrolysis
of palmitoyl-CoA was used to measure the thioesterase activity of rLipGMTB. As shown in Figure 2C, rLipGMTB also
exhibited a thioesterase activity with an S.A value of 2.10 +− 0.59 mU/mg. It is noteworthy that this value is of the
same order of magnitude as that of TesA, a thioesterase of M. tuberculosis [42] with a S.A of 5.95 +− 0.85 mU/mg.
In order to investigate further rLipGMTB enzyme activity, its phospholipase activity was also investigated. Inter-
estingly, rLipGMTB was able to hydrolyze only fluorescent phospholipids present at the sn−1 stereospecific position
with S.A value of 2.75 +− 0.25 mU/mg (Figure 2D) suggesting that rLipGMTB is a strict PLA1. T. lanuginosus lipase
PLA1 (TL PLA1) and Bee venom PLA2 (Bv PLA2) were used as positive controls for the PLA1 and PLA2 activities,
respectively.
Finally, sinceRastogi et al. [21] had proposed that the catalyticmachinerywas governed by Ser123, we thus generated
by site-directed mutagenesis a rLipGMTBS123A variant, in which this Ser123 residue was mutated into an Ala residue.
As predicted, no enzyme activity was observed with fluorescent-phospholipids, pNP-substrates or palmitoyl-CoA
with this inactive mutant (Figure 2E and data not shown). Taken together, these data provide full evidence that Ser123
contained in the consensus sequence G121ASMG125 is the catalytic residue responsible for the enzyme activity, and
consequently, confirms that LipGMTB is a true serine hydrolase. More specifically and given the level of S.A reached
with the various substrates investigated, our results suggest that rLipGMTB is a phospholipase A1 enzyme which also
displays esterase and thioesterase activities.
rLipGMTB is inhibited by OX derivatives and CyC analogs
Two series of recently reported antitubercular inhibitors discovered in our laboratory (OX derivatives and CyC
analogs), exhibit activity against enzymes by forming a covalent bond with the catalytic serine or cysteine residue
in their active sites [27–29]. In order to further investigate the ability of these compounds to efficiently inhibit the
lipolytic activity of rLipGMTB, six OX derivatives (i.e.MmPPOX, iBPOX, iBpPPOX,HPOX,HpPPOX, and BePOX)
[27]; and five CyC analogs (i.e. the CyC17, CyC7α, CyC7β, CyC8α, and CyC8β) [28,29] were then tested for inhibition
of rLipGMTB. In our previous work, whereas iBpPPOX, and CyC7β and CyC8α exhibited strong activity against both
extracellular and intramacrophagicM. tuberculosis; iBPOX andHpPPOX, and CyC7α and CyC8β were found active
on infected macrophages only [28,42]. In contrast, HPOX and BePOX, and CyC17 efficiently block M. tuberculosis
growth in vitro with no activity against intracellular bacilli [28,42].Orlistatwhich has been previously reported as an
inhibitor of LipG was used as positive control [63]. The chemical structures of the 12 compounds used in this study
are provided in Supplementary Figure S2.
rLipGMTB was inactivated by all the six OX derivatives, with medium 60.6% to good 93.8% inhibition levels at xI
= 100 (Table 2). The best inhibitors were HPOX, MmPPOX, and HpPPOX, which displayed inhibitor molar excess
leading to 50% enzyme inhibition, i.e. xI50 values of∼3.0 (Table 2 and Figure 3A). Amongst the CyC analogs, CyC7β,
CyC8α, and CyC8β exhibited very weak inhibitory effects up to a high molar excess xI = 100. Whereas, a strong
dose-dependent inhibition was observed with CyC17 and CyC7α (Table 2 and Figure 3B). In particular, CyC17 was
found to react almost stoichiometrically with rLipGMTB, as confirmed by its xI50 value of 0.98. It is noteworthy, that
Orlistat, used as reference inhibitor, displayed only a moderate inhibitory activity against pure rLipGMTB with only
69.5% inhibition at xI = 100 and a xI50 value of 15.2, similar to those of iBpPPOX, iBPOX, and BePOX.
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Table 2 Inhibition of rLipGMTB after a 30-min incubation period with each inhibitor1
Compounds % inhibition xI50
xI = 4 xI = 100
MmPPOX 54.1 +− 1.5 82.0 +− 3.8 3.1
iBpPPOX 40.5 +− 3.1 60.6 +− 0.22 14.7
iBPOX 32.7 +− 0.70 80.3 +− 0.90 15.0
HpPPOX 61.8 +− 4.7 73.8 +− 1.0 3.5
HPOX 58.5 +− 1.4 93.8 +− 5.7 2.9
BePOX 9.8 +− 0.28 68.8 +− 1.1 12.5
CyC7α 47.4 +− 0.81 81.4 +− 1.6 5.0
CyC7β 7.9 +− 0.72 57.6 +− 2.0 48.1
CyC8α 2.5 +− 0.10 51.3 +− 2.6 58.5
CyC8β 3.2 +− 0.16 32.0 +− 1.5 >200
CyC17 66.4 +− 4.5 95.4 +− 2.6 0.98
Orlistat 10.8 +− 0.17 69.5 +− 5.3 15.2
1Inhibition data (% of initial activity), at inhibitor molar excess (xI ) of 4 and 100 related to 1 mol of enzyme. Results are expressed as mean values +− S.D.
of at least three independent assays. The inhibitor molar excess leading to 50% lipase inhibition, xI50, was determined as described in Experimental
procedures section.
rLipGMTB and rLipGMS are peripheral membrane protein
Although LipGMTB has been identified in the membrane fraction of M. tuberculosis H37Rv by using proteomic
profiling approach [64], in silico experiments performed using SignalP 4.1 server [65] revealed that neither a pep-
tide signal for the general secretion pathway or for the twin-arginine translocation pathway, nor a Type VII consen-
sus secretion motif YxxxD/E were present in the primary sequence of LipG proteins. In this context, recombinant
M. smegmatis strains, overexpressing either rLipGMS (i.e. MSMEG 1352 gene) or rLipGMTB (i.e. Rv0646c gene)
cloned under the control of the hsp60 promoter in frame with a C-terminal 6× His-tag, were subjected to subcellu-
lar fractionation followed by immunoblotting experiments. The well-characterized cell wall exported monoglyceride
lipase, MSMEG 0220, was used as control for cell fractionation [52,53]. In each case, both proteins were found only
within the cell wall fraction and not in the soluble cytoplasmic fraction suggesting that LipG is a membrane/cell
wall-associated protein (Figure 4A,B). Additional differential detergent extraction of surface-exposed mycobacterial
proteins using Genapol R©-X080 [54,55], followed by precipitation and immunoblotting (Figure 4C), demonstrated
that LipG protein remains associated with the pellet fraction. This results suggest that this enzyme would not be ac-
cessible to the detergent and thus is not a surface-exposed protein. In contrast, MSMEG 0220 was found within the
supernatant fraction, as expected (Figure 4C). All these data strengthen the fact that mycobacterial LipG are periph-
eral proteins, interacting with the inner leaflet of the cytoplasmic membrane.
To go further, the dynamic location of LipG within living cells was investigated by using fluorescence microscopy
[66]. Gene fusions between Rv0646c orMSMEG 1352 and the sfGFP gene encoding the sfGFP [67] were generated
and used to transformM. smegmatis cells. Recombinant clones harboring stable fusions (Supplementary Figure S3)
with a constant and important expression level were grown to mid-log exponential phase (i.e. OD600 = 1) in classical
7H9-S medium and further analyzed by fluorescence microscopy. As shown in Figure 4D (right panel), the strains
harboring LipGMTB-sfGFP chimeric construct emitted a strong fluorescence signal mainly localized at the periphery
of the inner mycobacterial cell membrane. In contrast, the fluorescence signal of the recombinant strain expressing
only a wild-type sfGFP was less intense and diffuse through the cytoplasmic compartment (Figure 4D, left panel).
Similar results were obtained when the bacteria was processed either at early exponential phase (i.e. OD600 = 0.2)
or at the stationary phase (i.e. OD600 = 3). These findings strongly suggest that the resulting chimeric LipG proteins
remain clustered into the bacterial cytoplasmic membrane whatever the phase of bacterial growth.
To get structural insights concerning LipGMTB and its potential interaction within the cytoplasmic membrane, a
3D structural model was built using the I-TASSER server [35,36]. The X-ray structure of Streptomyces lividans
methylesterase RdmC (PDB id: 1Q0R), solved at 1.45 A˚ resolution was used as a template [68]. This generated model
revealed that LipGMTB is a serine hydrolase constituted by 11 α-helices and 8 β-strands that are forming a central
β-sheet (Supplementary Figure S4) as previously described [21]. A putative catalytic triad composed by Ser123, Asp251,
and His279 is located within a highly accessible active site surrounded by hydrophobic residues forming the catalytic
pocket (Supplementary Figure S4). In an effort to better characterize the molecular interactions that might govern
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Figure 3. Inhibition studies of rLipGMTB by OX derivatives and CyC analogs
Residual activities of LipGMTB measured on pNP-C6 as substrate. Effects of increasing molar excess (xI) of compounds (A)
MmPPOX, HpPPOX, HPOX, and (B) CyC7α, CyC17 and Orlistat on the rates of hydrolysis of pNP-C6. LipGMTB was pre-incu-
bated at various inhibitor molar excess (xI) for 30 min at 25◦C. Kinetic assays were performed as described in Experimental
procedures section. Results are expressed as mean values +− S.D. of three independent assays.
LipG binding on to the inner cell membrane, the electrostatic surface potential of the previously built 3D model
structure of LipGMTB (Supplementary Figure S4)was generated and is displayed in Figure 4E,F. Interestingly, a positive
electrostatic patch located opposite to the active site, on top of the model structure, was found. Notably, this specific
amino-acid patch is mainly constituted by six arginine residues highly conserved in several LipG orthologs (Figure
4E,F and Supplementary Figure S5). Such arginine residues, which are indeed known to play important role in protein
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Figure 4. Subcellular location of LipG proteins
(A,B) Subcellular localization of LipGMS and LipGMTB in M. smegmatis groEL1ΔC determined by ultracentrifugation. Recombinant
cells expressing 6× His-tagged LipG were lysed, total lysate (TL), cytoplasm (Cyt), and cell wall (CW) fractions were separated
by ultracentrifugation. Samples were loaded on to 12% SDS/PAGE and immunoblotted using HisProbe reagent. The exported
MSMEG 0220was used as control. (C) Determination of cell-surface-exposition of LipGMS and LipGMTB inM. smegmatis groEL1ΔC
by detergent extraction. Recombinant cells expressing 6× His-tagged LipG were treated with PBS-buffer or with PBS-buffer con-
taining Genapol R©-X080 detergent. Pellet (P) and supernatant (S) fractions containing cytoplasmic and surface-exposed proteins
respectively, were separated by centrifugation. Samples were loaded on to 12% SDS/PAGE and immunoblotted using HisProbe
reagent. The exported MSMEG 0220 was used as a control. (D) Fluorescence microscopy analysis of M. smegmatis groEL1ΔC
strains carrying either WT sfGFP gene or lipGMTB-sfGFP translational fusions. Cells were analyzed in both phase contrast (upper
panel) and fluorescent channels (bottom panel). Scale bars represent 1 μm. (E) Electrostatic potential of LipGMTB 3D model. The
electrostatic surface potentials were displayed color-coded on to a van der Waals surface using the PyMOL Molecular Graphics
System (version 1.8, Schro¨dinger, LLC). Red and blue colors represent net negative and positive charges, while white color repre-
sents overall neutral positions, respectively Black lines are showing the catalytic pocket. Two rotations of 90◦ were performed in
order to provide a better view of the high potential area on top of the protein. (F) Position of positively charged residues in LipGMTB
3D model. Positives residues were highlighted in orange. The two rotations of 90◦ were conserved in order to provide a better view
of the positively charged residues on top of the protein. An arginine-rich patch has been identified and position of the respective
residues (R234, R237, R238, R260, R264 and R270) are marked with black arrows.
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Table 3 Susceptibility testing of M. smegmatisWT and mutant strains
MIC50 (μg/ml)1 Fold change compared with WT
INH RIF Orlistat CyC17 INH RIF Orlistat CyC17
WT 1.4 0.76 0.97 0.56 - - - -
lipGMS::Hyg 2.9 3.3 6.5 9.6 ×2.0 ×4.3 ×6.7 ×15.7
lipGMS::Hyg
Comp
1.8 0.89 1.2 0.60 ×1.2 ×1.2 ×1.3 ×0.94
lipGMS::Hyg
CompMTB
1.9 0.96 1.6 0.65 ×1.3 ×1.3 ×1.6 ×1.1
1MIC50 values corresponding to the compound minimal concentration leading to 50% growth inhibition have been determined by the REMA method
and are expressed as mean values of three independent assays performed in duplicate.
binding to zwitterionic and anionic glycerolipid polar head groups [69,70], might thus contribute to the binding of
LipG to the cytoplasmic membrane (Figure 4E,F).
Disruption of MSMEG 1352 triggers cell wall modiﬁcations
In order to identify the physiological role of the LipG proteins within the mycobacterial lifecycle, a M. smegma-
tis MSMEG 1352 disrupted strain named lipGMS::Hyg , in which the gene has been interrupted with a hygromycin
resistance cassette, as well as a lipGMS::Hyg complemented strain (i.e. lipGMS::Hyg Comp) were produced (Supple-
mentary Figure S6). When grown in 7H9-S medium for 48 h at 37◦C, no significant differences in growth rate were
observed between the WT, lipGMS::Hyg , and lipGMS::Hyg Comp strains. Interestingly, when the strains were grown
on to 7H11TG agar plates (i.e. 7H11 medium supplemented with 0.02% Tween 80 and 0.2% glycerol), no differences
in colony morphologies were observed with naked eyes. In contrast, when agar plates were spot-inoculated on to the
same medium devoid of detergent and observed under a stereomicroscope, the lipGMS::Hyg mutant strain harbored
a slightly smoother and rounder phenotype than the WT and lipGMS::Hyg Comp strains (Figure 5A). This finding
would suggest that disruption of lipGMS may trigger some minor cell surface modifications (Figure 5A). TLC analy-
sis of total lipid extract reveals that disruption of lipGMS induces a slight but significant overproduction of GPLs by
1.35-fold compared withWT strain (Figure 5B). In contrast, no detectable changes were observed within FAMEs and
MAMEs levels as well as phospholipid content between each strain (Supplementary Figure S7A,B).
Although bacterial cell wall remodeling (including misregulation of GPL production) may also affect
biofilm/pellicle formation, neither global nor visible modifications where observed amongst the WT, lipGMS::Hyg ,
and lipGMS::Hyg Comp strains regarding pellicle formation (Supplementary Figure S7C) in 7H9-S medium contain-
ing either glycerol or acetate as carbon source.
Since the mycobacterial cell wall is the first effective barrier against bactericidal compounds, we hypothesized that
increase inGPLs could also play an important role in cell wall integrity. To answer this question, theWT, lipGMS::Hyg ,
and lipGMS::Hyg Comp strains were subjected to antibiotic susceptibility testing toward standard antibiotics INH and
RIF, using the REMA method [28,59] (Figure 5C and Table 3). The effects of Orlistat, HPOX as well as the CyC17
inhibitor on the growth of each strains were also investigated.
It is noteworthy that the respectiveMIC50 values obtainedwith INH (0.76μg/ml), RIF (1.4μg/ml), andCyC17 (0.56
μg/ml) against the WT strain are in accordance with previously published studies (Figure 5C and Table 3) [28,29].
Regarding Orlistat, this well-known serine hydrolase inhibitor [23,71] is able to impair M. smegmatis growth with
an MIC50 of 0.97 μg/ml. Surprisingly, deletion of lipGMS leads to an increased drug tolerance toward the four com-
pounds. As depicted in Figure 5C and Table 3, MIC50 of INH, RIF,Orlistat, andCyC17 against the lipGMS::Hyg strain
amounted to 2.9, 3.3, 6.5, and 9.6 μg/ml, respectively, thus corresponding to a respective fold change compared with
the WT strain of ×2.0, ×4.3, ×6.7, and ×15.7. The complementation of the mutant strain with the pVV16::lipGMS
restored the drug susceptibility with mean MIC50 fold change compared with WT strain of approximately ×1.2 to
×1.3.
Similar results were obtained withHPOX inhibitor. MIC50 values of 8.4 and 18.4 μg/ml were obtained for the WT
and lipGMS::Hyg strains, respectively; leading to a fold change compared with the WT strain of ×2.2. However, with
this compound the complementation with pVV16::lipGMS vector only partially restored the drug susceptibility with
an intermediate MIC50 value of 12.2 μg/ml (i.e. fold change compared with WT strain of approximately ×1.5).
Finally, we also carried out these experiments by performing complementation of the lipGMS::Hyg strain with the
pVV16::lipGMTB vector (lipGMS::Hyg CompMTB). Interestingly, production of LipGMTB protein was perfectly able
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Figure 5. Disruption of lipGMS triggers cell-wall modiﬁcations and decreases antibiotics susceptibility
(A) Colony morphology of WT, lipGMS disrupted and complemented strains. Recombinant strains were grown in 7H9-S before being
spotted on to Middlebrook 7H11 agar plate devoid of Tween-80. Images are representative of two independent experiments. (B)
GPL analysis of WT, lipGMS disrupted and complemented strains. Cells were grown in 7H9-S until OD600 nm ∼1–1.5. Lipid extraction
was followed by TLC (left panel) and densitometry analysis (right panel). Results are expressed as mean +− S.D. of total GPL level
from three independent experiments, where WT level was arbitrarily adjusted to 1 relative unit. Statistical analysis was performed
by using the Student’s t test. Relative GPL level from lipGMS disrupted mutant were compared with the WT where * corresponded
to a P-value <0.05. Relative GPL level from lipGMS complemented strain were compared with the lipGMS disrupted mutant where
# corresponded to a P-value <0.05. (C) Antibiotic susceptibility of WT, lipGMS disrupted and complemented strains. Susceptibility
toward INH, RIF, andCyC17 were determined using the REMA. Fluorometric MIC50s were determined by fitting the RFU% sigmoidal
dose–response curves. Graph fitting are representative of three independent assays performed in duplicate.
to restore the drug susceptibility, suggesting that the two proteins may possess similar enzymatic activities and/or
physiological functions (Table 3).
To further confirm this result, the recombinant rLipGMS was produced, purified, and biochemically characterized
as described above for rLipGMTB (Supplementary Figure S8 and Table S2). Both pure rLipGMS and rLipGMTB pro-
teins thus exhibit the same substrate specificity toward pNP ester substrates, the best S.A being also found with pNP
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caproate (C6). Moreover, rLipGMS was also able to hydrolyze acyl-CoA and phospholipids as substrates, confirming
that the substrate specificity is well conserved between the two proteins. Despite their similar reactivity pattern with
various esters, we noticed, however, that the rLipGMS wasmore active than its ortholog (Supplementary Table S2). In-
terestingly, these differenceswhere only observed in vitro using pure proteins, but not during trans-complementation
with the lipGMTB gene during in vivo experiments as described above.
Overexpression of lipGMTB impacts free fatty acids and phospholipids
homeostasis
Despite the observed impact of lipGMS gene disruption on to the penetration/diffusion of the latter antitubercu-
lar molecules within the mycobacterial envelope, no clear detectable phenotype has been observed. To overcome
such issue, a recombinant strain harboring the pMyC::lipGMTB plasmid which allows a strong overproduction of the
LipGMTB protein upon acetamide induction, has been constructed. Approximately 6 and 24 h following induction
by acetamide, total lipid extraction was performed on cell cultures either in exponential (OD600 ∼1–1.5) or station-
ary (OD600 ∼3–4) phase, respectively. The effect of LipGMTB overproduction was scrutinized by TLC analysis. As
expected from our previous results which showed a slight increase in GPL production in absence of LipGMS (Figure
5A,B), in the strain overproducing LipGMTB (Figure 6A), a clear drop in GPLs production was observed at 6 h (61 +−
8%) and 24 h (51 +− 12%) post-induction when compared with the WT strain harboring the empty pMyC vector as
reference. However, in contrast withM. smegmatis, the fact thatM. tuberculosis H37Rv does not produce GPLs may
suggest a different functional role of LipG in this latter mycobacteria. This prompted us to further analyze other lipid
subclasses. Accordingly, a semi-quantitative analysis of M. smegmatis strains harboring pMyC and pMyC::lipGMTB
revealed that the overproduction of the protein significantly increases the level of FAMEs by 1.42-fold and 1.25-fold
compared with control strain at 6 and 24 h post-induction, respectively (Figure 6B), without affecting MAMEs level
or ratio.
Regarding phospholipid levels, surprisingly overexpression of lipGMTB slightly increases the phospholipid level of
phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) subspecies (1.75- and 1.07-fold in comparison with
the control strain, respectively), but more importantly, this overproduction drastically impacts phosphatidylinositol
(PI) production with a fold-change related to the control strain of ×2.3 (Figure 6C). These results were further con-
firmed by using 2D-TLC analysis, where a nice and efficient separation of all species of phospholipids allowed to
confirm a consequent increase in PI biosynthesis upon LipGMTB overproduction (Supplementary Figure S9).
Altogether, the increase in the levels of both FAMEs and specific subclass of phospholipids suggest that the LipGMTB
acyl-CoA-thioesterase activity may be the predominant biochemical activity in vivo, and that the products of the
reaction are directly influencing cell wall phospholipids composition.
Discussion
M. tuberculosis is one of the most successful infectious agents worldwide. Therefore, understanding the molecular
mechanisms responsible for its pathogenesis remains one of the most important challenges in TB fundamental re-
search. By using highly elaborate genetic screens, several independent teams have indeed tried to identify the genes
required for in vitro or in vivo bacterial survival [26,72,73]. These approaches have highlighted the Rv0646c gene of
M. tuberculosis which is required for adaptation and survival of the bacilli in mousemacrophages [26]. Interestingly,
this gene has been annotated as encoding a putative lipase/esterase protein based on the presence of a G-x-S-x-G con-
sensus pentapeptide motif. More importantly, the Rv0646c gene encoding LipGMTB is widely conserved through the
Mycobacterium genus and is associated with a gene cluster involved in MAs maturation processes [19]. Strikingly,
bioinformatics analysis demonstrated that this gene is highly conserved in both slow- and fast-growingmycobacteria,
and even in the obligate intracellular parasiteM. leprae. This latter unusual pathogen is harboring a genome with a
large number of inactivated pseudogenes which are not required anymore in vivo [74]. However, amongst the 24
genes encoding lipolytic enzymes from the Lip family inM. tuberculosis, only lipE, lipU, and lipG are conserved in
M. leprae, thus reinforcing an essential role played by these enzymes in intracellular survival and proliferation [74,75].
In this study based on biochemical characterization of rLipGMTB protein associated with microbiology experiments,
we uncovered the potential role of this enzyme in mycobacterial lipid metabolism.
In accordance with a recent report, we confirmed that recombinant LipGMTB protein is an esterase acting pref-
erentially on medium chain-length substrates [21,75]. More interestingly, we also found that the protein was able
to hydrolyze phospholipids at the sn−1 position and cleave the thioester bond from palmitoyl-CoA, showing that
rLipGMTB possesses esterase and phospholipase, as well as thioesterase activities (Figure 2). Both phospholipase and
thioesterase activities have been already observed by Parker et al. [62], who described thatM. tuberculosis Rv3802c
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 6. LipGMTB impacts free fatty acids and phospholipids biosynthesis
Mycobacterial cultures harboring pMyC and pMyC::lipGMTB were grown in 7H9-S medium until reaching OD600 nm ∼0.5, then 0.2%
of acetamide was added inside the culture medium. Cells were collected at 6 or 24 h post-induction corresponding to exponential
or stationary phase, lyophilized and the same amount of dry cell weight was use for lipid extraction. After normalization, the same
volume of each sample was loaded on to TLC. (A) Global GPL levels are decreasing in anM. smegmatis pMyC::lipGMTB overexpres-
sion strain. Lipid extracts of each samples were analyzed by TLC followed by densitometry analysis. (B) FAMEs levels are increasing
in an M. smegmatis pMyC::lipGMTB overexpression strain. Lipid extracts of each samples were analyzed by TLC followed by den-
sitometry analysis. In each case, results are expressed as mean +− S.D. of each respective total lipid species levels from at least two
independent experiments, where control strain level at t6 h was arbitrary adjusted to 1 relative unit. (C) Phospholipid biosynthesis is
increased in anM. smegmatis pMyC::lipGMTB overexpression strain. Lipid extracts of each samples were analyzed by TLC followed
by densitometry analysis. TLC was performed with CHCl3-MeOH-H2O (65:25:4; v/v/v) as eluent and PI overproduction is indicated
with a red asterisk (left panel). Lipid sample fromM. smegmatis pMyC::lipGMTB at t6 h was also co-injected with pure PI standard as
control lane, to clearly identify PI as an overproduced subspecies. Histograms correspond to densitometry analysis at t6 h. Results
are displayed as intensity ratio where phospholipids levels from the pMyC::lipGMTB strain were divided by the phospholipids levels
from the pMyC strain (right panel). Results are expressed as mean +− S.D. from three independent experiments. Statistical analysis
was performed by using the Student’s t test where * correspond to a P-value <0.05. Abbreviation: PI, phosphatidylinositol.
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gene (cut6) encodes a functional phospholipase/thioesterase protein. Using radiolabeled phospholipids coupled with
TLC analysis, the authors showed that Cut6was not only able to act on PE, PC, and phosphatidylserine (PS)molecules
[62], but that it was also able to hydrolyze both palmitoyl- and decanoyl-CoA, suggesting that the protein may act as
an acyl donor in vivo.
The fact that LipG was required for adaptation and survival within macrophages, prompted us to investigate the
inhibitory properties of two new series of serine hydrolase inhibitors active againstM. tuberculosis growth [27–29].
During in vitro inhibition experiments on pure protein (Figure 3 and Table 2), the best inhibitors from the two
series of compounds were HPOX (for the OX derivatives) on the one hand, and CyC17 (for the CyC analogs) on the
other hand; two molecules that are only active against extracellularly growingM. tuberculosis strain [27,28]. In the
case ofCyC17, this result was a posteriori predictable. Following activity-based protein profiling experiment coupled
with proteomics analyses [28], LipG was indeed found as a potential target of this compound from a lysate of M.
tuberculosis (unpublished data). However, its low coverage (21% sequence identity) with only five distinct peptide
sequences identified together with a peptide score ∼2.0–3.4 (given by SequestHT algorithm) made that this protein
was below our threshold and was not selected. Conversely, LipG was not identified from similar ABPP experiments
performed withHPOX directly on livingM. tuberculosis cells [27]. We recently demonstrated that both theOX and
CyC families of compound aremultitarget inhibitors, which are probably displaying pleiotropic and cumulative effects
toward mycobacterial Ser- and Cys-containing enzymes involved in lipid metabolism and/or cell wall maintenance,
thus leading toM. tuberculosis growth arrest [27,28]. From these findings and despite their strong inhibitory effect
in vitro on pure LipG enzyme, we thus proposed that in vivo HPOX andCyC17 preferentially impair other previously
identified target enzymes such as the Ag85 complex or the thioesterase TesA rather than LipGMTB.
Based on proteomic analysis of theM. tuberculosismembrane fraction, it has been recently proposed that LipGMTB
may be localized to the cell surface and directly interact with the host immune system [21,64]. However, bioinformat-
ics analysis did not reveal the presence of any secretion signals or specific motifs, which may indicate that the protein
is surface exposed. Herein, using different cell-fractionation approaches, we demonstrated that LipGMTB is associ-
ated with the membrane fraction [54,55,66], but not translocated across the cytoplasmic membrane and remains a
cytoplasmic protein which is mainly peripheral (Figure 4). It has been described that such peripheral proteins re-
quire either a lipophilic attachment (i.e. acylation) or the presence of basic residues positively charged [69,70] which
induce electrostatic interaction with the acidic and negatively charged phospholipids head-groups, thus allowing an-
choring of the protein within the cytoplasmic membrane [70]. Based on our 3D structure model, surface electrostatic
potential analysis allows identification of a region on top of the active site mainly composed by positively charged
residues (Figure 4E,F). This area is essentially constituted by a C-terminal cluster of arginine residues fully conserved
in numerous LipG proteins (Supplementary Figure S5). Since this type of electrostatic interaction has already been
described for a mycobacterial protein involved in acyl-CoA metabolism [76], one can assume that this cluster of Arg
residues would play an important role in LipG binding to the cell membrane, and thus for its physiological function.
In contrast withCut6, which is known for being secreted and acting outside themycobacterial cell [62,77], LipGMTB
and LipGMS are presumably hydrolyzing cytoplasmic substrates. Two distinct strategies were employed: (i) the gen-
eration of a lipGMS disrupted strain which was trans-complemented with either lipGMS or lipGMTB and (ii) the gen-
eration of a lipGMTB heterologous overexpression strain which were useful in identifying the potential physiological
role of LipG proteins and to define their substrates in vivo. On one hand, the observed increase in GPLs production
due to lipG gene disruption (Figure 5) resulted in a significant reduced susceptibility to RIF, INH, Orlistat, HPOX,
and above all CyC17 for which the highest fold change compared with WT strain in MIC50 value has been reached
(Table 3). Since RIF and INH are inhibiting specifically cytoplasmic targets, we hypothesized that such increase in
GPL will affect cell wall fluidity and integrity; which subsequently impacts the penetration of the main two first-line
anti-TB drugs [78]. Such results are in agreement with Khoo et al. work [79] who reported that Mycobacterium
avium GPLs positive serovar were less sensitive to ethambutol than GPLs negative serovar, and concluded that hy-
drophobic GPLs production may alter cell wall permeability and correlate with antibiotic tolerance [79]. In other
hand, the overproduction of the LipGMTB protein leads to a significant increase in the FAMEs level (1.42-fold and
1.25-fold at 6 and 24 h post-induction, respectively), but more importantly a decrease in GPLs levels withinM. smeg-
matis concomitant to an increase in level of phospholipid species and more particularly, the phosphatidyl inositol
(Figure 6). However this is not the first time that such modifications of the cell wall composition have been observed.
Similar phenotypes with drastic alteration of FAMEs/MAMEs and phospholipid subspecies levels have already been
described in 2009, by Meniche et al. [58]. The authors demonstrated that overexpression of the Corynebacterium
glutamicum gene NCgl2775 encoding a functional thioesterase/phospholipase protein leads to an increase in MAs
production concomitantly with a decrease in glycerophosphoslipids levels [58]. A similar result was also obtained
when theMSMEG 6394 protein (i.e. NCgl2775 and Cut6 orthologs) was overproduced, which prompted the authors
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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to propose that this kind of bifunctional enzyme is may be able to regulate membrane compositions under specific
conditions [58].
Since not all the mycobacterial strain are GPLs producers, especially M. tuberculosis H37Rv, we postulated that
this phenotype was more an indirect effect, than a direct catabolic process transposable toM. tuberculosis.
From all these findings, it is tempting to propose that LipG is mainly acting as a thioesterase dedicated to phos-
pholipid metabolism in vivo. In a large number of bacteria, the contribution of thioesterase proteins to phospholipid
biosynthetic process is however not well-defined. For example, in E. coli, glycerol starvation leads to an increase in
acyl-ACP and a drastic diminution of phospholipid levels. Overexpression of TesA, a type I thioesterase, drastically
reduced the accumulation of long-chain acyl-ACP species, probably by rerouting free fatty acids to phospholipids
[80]. It has also been proposed that the ybgC gene encoding a functional acyl thioesterase is playing a role in phos-
pholipid metabolism in Gram-negative bacteria [81–83]. Astonishingly, this latter enzyme is known for interacting
with a large number of proteins dedicated to phospholipid homeostasis, such as the acyl-carrier protein, the glycerol
3-phosphate acyltransferase (PlsB), and the PS synthase (PssA) [82]. Such systems dedicated to phospholipids have
not been described so far in mycobacteria, but a similar multicomponent complex is involved in MA biosynthesis
[16,17]. Overall, it might be possible that some proteins work together in order to respond to specific stimuli and
thus modulate biological membrane composition and fluidity. Such a physiological process has also been reported
in eukaryotic cells, where upon inflammatory stimulus, the acyl-CoA thioesterase 7 (ACOT7) converts acyl-CoA
molecules into free fatty acids, thus triggering a remodeling of phospholipid containing unsaturated long (≥C20)-acyl
chains in macrophages [84].
Finally, PI is known for being an essential and abundant phospholipid species within mycobacterial cytoplasmic
membrane [85], but also for being a major precursor for complex glycoconjugated lipids such as phosphatidyl man-
nosides, lipomannan, or lipoarabinomannan [86,87]. Observation of an important increase in PI subspecies during
LipGMTB overproduction may also impact the formation of such glycolipids that are highly contributing to virulence
andmodulation of the host immune response. The potential role of the LipGMTB protein within these pathways is cur-
rently under investigation in our laboratory and may bring new insight concerning the biosynthesis of such complex
lipids, but also the role of this highly conserved protein during host–pathogen cross-talk.
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